ZA886284B - Controlled release formulations - Google Patents

Controlled release formulations

Info

Publication number
ZA886284B
ZA886284B ZA886284A ZA886284A ZA886284B ZA 886284 B ZA886284 B ZA 886284B ZA 886284 A ZA886284 A ZA 886284A ZA 886284 A ZA886284 A ZA 886284A ZA 886284 B ZA886284 B ZA 886284B
Authority
ZA
South Africa
Prior art keywords
controlled release
release formulations
formulations
controlled
release
Prior art date
Application number
ZA886284A
Other languages
English (en)
Inventor
Martin Katz
Katz Martin
Chung-Heng Cheng
Cheng Chung-Heng
Richard Won
Won Richard
Helen C Leong
C Leong Helen
Original Assignee
Advanced Polymer Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Polymer Systems Inc filed Critical Advanced Polymer Systems Inc
Publication of ZA886284B publication Critical patent/ZA886284B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0279—Porous; Hollow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
ZA886284A 1987-08-31 1988-08-24 Controlled release formulations ZA886284B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9164187A 1987-08-31 1987-08-31

Publications (1)

Publication Number Publication Date
ZA886284B true ZA886284B (en) 1990-04-25

Family

ID=22228867

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA886284A ZA886284B (en) 1987-08-31 1988-08-24 Controlled release formulations

Country Status (6)

Country Link
EP (1) EP0306236B1 (xx)
JP (1) JP2909078B2 (xx)
KR (1) KR960013701B1 (xx)
AU (1) AU613398B2 (xx)
DE (1) DE3880593T2 (xx)
ZA (1) ZA886284B (xx)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA892859B (en) * 1988-04-22 1989-12-27 Advanced Polymer Systems Inc Porous particles in preparations involving immiscible phases
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US4961532A (en) * 1989-07-07 1990-10-09 Dow Corning Corporation Fragrance release device containing a highly adsorptive copolymer
FR2685635B1 (fr) * 1991-12-27 1995-06-30 Lvmh Rech Particules solides complexes comprenant une substance solide biologiquement active, leur mode de preparation et compositions a usage topique les renfermant destinees au traitement de surfaces biologiques.
US4962133A (en) * 1989-09-05 1990-10-09 Dow Corning Corporation Method of making highly adsorptive copolymers
US5037485A (en) * 1989-09-14 1991-08-06 Dow Corning Corporation Method of cleaning surfaces
DE69024363T2 (de) * 1989-10-03 1996-07-04 Advanced Polymer Systems Inc Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung
US5102662A (en) * 1989-12-08 1992-04-07 Dow Corning Corporation Insect repellent plastic
US5208038A (en) * 1989-12-08 1993-05-04 Dow Corning Corporation Coacervated highly absorptive polymers
US5246972A (en) * 1990-04-06 1993-09-21 Dow Corning Corporation Polish containing highly adsorptive polymer
WO1991019483A1 (en) * 1990-06-20 1991-12-26 Advanced Polymer Systems, Inc. Compositions and methods for the controlled release of soluble active substances
DE69116989D1 (de) * 1990-06-28 1996-03-21 Edko Trading Representation Mehrphasige pharmazeutische Zusammensetzungen
FR2666015B1 (fr) * 1990-08-23 1994-11-10 Oreal Composition cosmetique et/ou dermopharmaceutique contenant de l'acide retinouique ou ses derives, destinee au traitement des cheveux ou du cuir chevelu.
US5387411A (en) * 1990-10-05 1995-02-07 Dow Corning Corporation Antiperspirant containing a hydrophobic macroporous polymer as the suspending agent
US5281413A (en) * 1990-10-05 1994-01-25 Dow Corning Corporation Antiperspirant stick containing a macroporous polymer
US5135660A (en) * 1991-01-07 1992-08-04 Dow Corning Corporation Method of recovering oil from the surface of water
US5145685A (en) * 1991-04-08 1992-09-08 Dow Corning Corporation Skin treatment method and composition
GB9211708D0 (en) * 1992-06-03 1992-07-15 Unilever Plc Cosmetic composition
CA2116238C (en) * 1992-06-22 2007-09-04 Joyce C. Knutson Oral 1 .alpha.-hydroxyprevitamin d
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
US6096344A (en) 1995-07-28 2000-08-01 Advanced Polymer Systems, Inc. Bioerodible porous compositions
GB9621825D0 (en) * 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
DE19724444C2 (de) * 1997-06-10 1999-07-15 Cospharcon Gmbh Transdermale Zubereitung und Verfahren zur Herstellung derselben
US6228894B1 (en) * 1998-04-17 2001-05-08 Enhanced Derm Technologies, Inc. Softgel-compatible composition containing retinol
KR100328972B1 (ko) * 1999-04-23 2002-03-20 서경배 피부 유용 활성성분을 함유한 화장료 또는 피부도포용 의약품 조성물의 제조방법 및 이러한 방법에 의해 제조된 화장료 또는 피부도포용 의약품 조성물
KR100348826B1 (ko) * 1999-11-12 2002-08-17 주식회사 태평양 수용성 활성성분의 피부 흡수도가 향상된 수중유형 화장료 조성물의 제조방법
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
FR2856594B1 (fr) * 2003-06-26 2006-03-03 Oreal Particules poreuses chargees en compose(s) actif(s) cosmetique(s) ou pharmaceutique(s)
US20050031699A1 (en) 2003-06-26 2005-02-10 L'oreal Porous particles loaded with cosmetically or pharmaceutically active compounds
JP2007533634A (ja) * 2003-09-30 2007-11-22 アキュスフィア， インコーポレイテッド 注射、経口、または局所用の徐放性医薬製剤
FR2874321B1 (fr) * 2004-08-17 2010-11-26 Oreal Composition topique comprenant des particules poreuses chargees et un compose absorbant le sebum
US7160958B2 (en) * 2005-05-09 2007-01-09 Geo Specialty Chemicals, Inc. Method of increasing the absorption rate of peroxides into polymer particles
DE102005045144A1 (de) * 2005-09-16 2007-03-29 Beiersdorf Ag Sonnenschutzmittel mit Ligninsulfonaten
DE102005045141A1 (de) * 2005-09-16 2007-03-29 Beiersdorf Ag Kosmetische Selbstbräunungsformulierungen
US20080206351A1 (en) * 2007-02-23 2008-08-28 Conopco, Inc., D/B/A Unilever Malodor Reduction of Cosmetic Products
FR2941972B1 (fr) * 2009-02-09 2011-05-27 Ab7 Ind Procede d'enduction de microspheres sur un materiau souple
FR2987561B1 (fr) 2012-03-02 2014-04-11 Pf Medicament Dispositif transdermique comprenant des micro-particules poreuses
JP5812374B2 (ja) 2012-09-26 2015-11-11 積水化成品工業株式会社 多孔質樹脂粒子、多孔質樹脂粒子の製造方法、およびその用途
EP2783678B1 (en) * 2013-03-28 2016-01-20 Sekisui Plastics Co., Ltd. Porous resin particles, method of manufacturing the same, and use of the same
GB201306607D0 (en) * 2013-04-11 2013-05-29 Xeros Ltd Method for treating an animal substrate
US9474720B2 (en) 2013-11-04 2016-10-25 BioPharmX, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
GB201417487D0 (en) 2014-10-03 2014-11-19 Xeros Ltd Method for treating an animal substrate
GB201418007D0 (en) 2014-10-10 2014-11-26 Xeros Ltd Animal skin substrate Treatment apparatus and method
GB201418006D0 (en) 2014-10-10 2014-11-26 Xeros Ltd Animal skin substrate treatment apparatus and method
AU2014413257B2 (en) * 2014-12-05 2019-05-09 Dow Global Technologies Llc Curable epoxy resin composition
EP3558467B1 (en) 2016-12-22 2023-06-07 Unilever IP Holdings B.V. Stabilization of cosmetic compositions comprising fish oils and hydroxylated fatty acids and/or its derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
DE3243591A1 (de) * 1982-11-25 1984-05-30 Hoechst Ag, 6230 Frankfurt Vinylencarbonat-polymerysate, verfahren zu ihrer herstellung und ihre anwendung
DE3485826T2 (de) * 1983-11-25 1992-12-10 Allied Colloids Ltd Herstellung und verwendung polymerer kugeln.
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen

Also Published As

Publication number Publication date
EP0306236B1 (en) 1993-04-28
DE3880593T2 (de) 1993-10-21
KR960013701B1 (en) 1996-10-10
EP0306236A3 (en) 1989-05-24
JP2909078B2 (ja) 1999-06-23
DE3880593D1 (de) 1993-06-03
AU613398B2 (en) 1991-08-01
EP0306236A2 (en) 1989-03-08
AU2164088A (en) 1989-03-23
JPH01131112A (ja) 1989-05-24
KR890003363A (ko) 1989-04-14

Similar Documents

Publication Publication Date Title
EP0306236A3 (en) Controlled release formulations
GB2207353B (en) Controlled release formulation
EG18523A (en) Substained release matrix formulations
EP0251459A3 (en) Controlled release pharmaceutical composition
AU556090B2 (en) Controlled release formulations
JPS6490279A (en) Silicone release
IL88148A0 (en) Somatotropin sustained release formulations
GB8712251D0 (en) Formulation
GB8521221D0 (en) Controlled release formulations
ZA896012B (en) Controlled release formulations
GB8924207D0 (en) Formulations
IE871503L (en) Sustained release formulations
GB8922061D0 (en) Controlled release formulations
GB8729673D0 (en) Formulations
ZA893966B (en) Controlled release composition
SG27194G (en) Sustained release etodaloc
AU589254C (en) Slow release formulations
EG17797A (en) Controlled release formulation
GB8716488D0 (en) Release mechanism
ZA881843B (en) Somatotropin prolonged release
IE863030L (en) Controlled release composition
GB8705453D0 (en) Insecticidal formulations
IE840461L (en) Controlled release formulation comprising a¹triazolobenzothiazole
IE871827L (en) Formulations comprising water-dispersible granules
GB8726653D0 (en) Release device